Insider Trading Roundup: Proteon Therapeutics, Inc. $PRTO

98d0cb80c5537d59061fae288bd8db4b

Proteon Therapeutics, Inc. (PRTO) insider have most recently took part in a trading activity. On Dec 15, 2017 Burke Steven Keith, SVP and Chief Medical Officer bought 12,000 shares having total worth of $22,560 at the price of $1.88 per share, following the transaction a total of 127,534 shares owned by Burke Steven Keith.

The stock has experienced a total of 2 insider trades in the past three months. These trades include 1 sell activities and 1 buy trades. Furthermore, over the past 12 months , the stock was traded 2 times by insiders. In 1 of these trades, the insider was a seller while an employee of the company was the buyer in 1 instances.

Time Frame Number of Insider Buy Number of Insider Sell Stock Price Change(%)
3 Month 1 1 42.31%
12 Month 1 1 -77.27%

Proteon Therapeutics, Inc. (PRTO) last announced its earnings results on Nov 7, 2017. The company reported -0.70 earnings per share (EPS) for the quarter, lower than the consensus estimate of -0.39 by $0.31. During the same quarter in the previous year, the company posted -0.43 earnings per share.

2017-11-07 2017-08-07 2017-05-10 2016-11-07 2016-08-08 2016-05-09 2016-03-14 2015-11-12 2015-08-13 2015-05-13
earnings per share -0.70 -0.33 -0.39 -0.43 -0.48 -0.40 -0.38 -0.33 -0.31 -0.28
Revenue(M) 0 0 0 0 0 0 0 0 0 0

William White

William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.

About the Author

William White
William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.